Moderna shells out for CEO security as its COVID-19 vaccine grabs the spotlight by Eric Sagonowsky | Apr 5, 2021 10:29am

Moderna stepped onto the world stage last year when they pivoted the company's mRNA research to target COVID-19, scaled-up manufacturing, staffed up a sales and marketing team and then launched a highly effective shot. 

Under that spotlight, CEO Stéphane Bancel and his team needed backup, Moderna decided. And the company brought in a security team to do just that.

In its annual proxy filing, the company disclosed that it shelled out more than $1 million on security for Bancel last year and spent smaller amounts on security services for other Moderna executives.

https://www.fiercepharma.com/pharma/riding-covid-19-vaccine-launch-moderna-shells-out-for-ceo-security?mkt_tok=Mjk0LU1RRi0wNTYAAAF8Vb7R6D8FqCmvzUfwhNrwinRwlEnNnjiZ_xkWMvn934GRIEEnVGs1KuW8Ph7dm-DVv-cbu784gTQwaqx-RJclTyEIox9zXkJ9GbOKUpBBK0nlrOJL&mrkid=1009778